- Home
- ZNTL vs GAMB Comparison
ZNTL vs GAMB Comparison
Compare ZNTL & GAMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- GAMB
- Stock Information
- Founded
- ZNTL 2014
- GAMB 2006
- Country
- ZNTL United States
- GAMB Jersey
- Employees
- ZNTL N/A
- GAMB N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- GAMB Services-Misc. Amusement & Recreation
- Sector
- ZNTL Health Care
- GAMB Consumer Discretionary
- Exchange
- ZNTL Nasdaq
- GAMB Nasdaq
- Market Cap
- ZNTL 105.8M
- GAMB N/A
- IPO Year
- ZNTL 2020
- GAMB 2021
- Fundamental
- Price
- ZNTL $1.62
- GAMB $7.59
- Analyst Decision
- ZNTL Buy
- GAMB Strong Buy
- Analyst Count
- ZNTL 6
- GAMB 8
- Target Price
- ZNTL $6.53
- GAMB $15.38
- AVG Volume (30 Days)
- ZNTL 685.5K
- GAMB 624.2K
- Earning Date
- ZNTL 11-11-2025
- GAMB 11-13-2025
- Dividend Yield
- ZNTL N/A
- GAMB N/A
- EPS Growth
- ZNTL N/A
- GAMB N/A
- EPS
- ZNTL N/A
- GAMB 0.40
- Revenue
- ZNTL $26,865,000.00
- GAMB $147,655,000.00
- Revenue This Year
- ZNTL N/A
- GAMB $38.38
- Revenue Next Year
- ZNTL N/A
- GAMB $11.69
- P/E Ratio
- ZNTL N/A
- GAMB $19.13
- Revenue Growth
- ZNTL N/A
- GAMB 27.57
- 52 Week Low
- ZNTL $1.01
- GAMB $7.51
- 52 Week High
- ZNTL $4.44
- GAMB $17.14
- Technical
- Relative Strength Index (RSI)
- ZNTL 52.30
- GAMB 31.01
- Support Level
- ZNTL $1.54
- GAMB $8.03
- Resistance Level
- ZNTL $1.84
- GAMB $8.41
- Average True Range (ATR)
- ZNTL 0.11
- GAMB 0.25
- MACD
- ZNTL 0.02
- GAMB -0.01
- Stochastic Oscillator
- ZNTL 44.59
- GAMB 1.57
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.